Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$1.42 +2.5%	$1.84	$0.90 ▼ $4.98	$356.21M	2.45	3.86 million shs	2.38 million shs
BLUA BlueRiver Acquisition		$11.09	$10.26 ▼ $11.45	$96.90M	N/A	26,528 shs	16,400 shs
RXST RxSight	$8.45 -4.1%	$10.06	$6.32 ▼ $58.23	$345.74M	1.16	1.04 million shs	1.08 million shs
SNWV Sanuwave Health	$39.45 +7.5%	$35.05	$5.21 ▼ $46.58	$338.01M	1.29	51,945 shs	52,748 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	-3.82%	0.00%	-25.94%	-36.03%	+42.12%
BLUA BlueRiver Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%
RXST RxSight	+3.77%	+19.86%	+19.86%	-44.97%	-83.32%
SNWV Sanuwave Health	-4.30%	-11.97%	-6.45%	+17.66%	+3,670,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFLY Butterfly Network	3.0321 of 5 stars	3.4	3.0	0.0	0.0	3.0	2.5	0.6
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RXST RxSight	1.5175 of 5 stars	3.0	1.0	0.0	0.0	1.6	1.7	0.6
SNWV Sanuwave Health	1.6866 of 5 stars	3.5	0.0	0.0	0.0	0.6	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	2.75	Moderate Buy	$3.00	112.01% Upside
BLUA BlueRiver Acquisition	0.00	N/A	N/A	N/A
RXST RxSight	1.91	Reduce	$10.00	18.34% Upside
SNWV Sanuwave Health	3.00	Buy	$49.00	24.21% Upside

Current Analyst Ratings Breakdown

Latest BLUA, BFLY, SNWV, and RXST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	RXST RxSight	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$16.00 ➝ $8.00
8/8/2025	RXST RxSight	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$9.00 ➝ $8.00
8/8/2025	RXST RxSight	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$22.00 ➝ $11.00
8/4/2025	BFLY Butterfly Network	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive	$2.00
8/1/2025	BFLY Butterfly Network	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
7/29/2025	SNWV Sanuwave Health	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$49.00
7/15/2025	RXST RxSight	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$20.00 ➝ $9.00
7/10/2025	RXST RxSight	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$24.00 ➝ $9.00
7/9/2025	RXST RxSight	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform ➝ Underperform	$18.00 ➝ $9.00
7/9/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$18.00 ➝ $10.00
7/9/2025	RXST RxSight	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$17.00 ➝ $9.00

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$87.52M	4.07	N/A	N/A	$0.92 per share	1.54
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A	($0.72) per share	N/A
RXST RxSight	$147.06M	2.35	N/A	N/A	$6.79 per share	1.24
SNWV Sanuwave Health	$39.19M	8.62	N/A	N/A	($1.72) per share	-22.94

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$72.49M	-$0.28	N/A	N/A	N/A	-71.79%	-30.53%	-21.80%	11/7/2025 (Estimated)
BLUA BlueRiver Acquisition	-$5.28M	N/A	0.00	N/A	N/A	N/A	N/A	-34.53%	N/A
RXST RxSight	-$27.45M	-$0.80	N/A	N/A	N/A	-21.93%	-11.56%	-10.31%	11/6/2025 (Estimated)
SNWV Sanuwave Health	-$31.37M	-$8.25	N/A	∞	N/A	-97.03%	N/A	-135.15%	N/A

Latest BLUA, BFLY, SNWV, and RXST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/8/2025	Q2 2025	SNWV Sanuwave Health	-$0.09	$0.01	+$0.10	$0.01	$10.14 million	$10.16 million
8/7/2025	Guidance Update	RXST RxSight	-$0.04	-$0.08	-$0.04	-$0.29	$39.78 million	$33.64 million
8/1/2025	Q2 2025	BFLY Butterfly Network	-$0.07	-$0.06	+$0.01	-$0.06	$23.91 million	$23.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
BLUA BlueRiver Acquisition	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A
SNWV Sanuwave Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	5.68	4.14
BLUA BlueRiver Acquisition	N/A	0.01	0.01
RXST RxSight	N/A	13.93	12.70
SNWV Sanuwave Health	N/A	0.43	0.31

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
BLUA BlueRiver Acquisition	22.34%
RXST RxSight	78.78%
SNWV Sanuwave Health	42.53%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	25.18%
BLUA BlueRiver Acquisition	78.98%
RXST RxSight	9.57%
SNWV Sanuwave Health	14.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	251.74 million	188.35 million	Optionable
BLUA BlueRiver Acquisition	3	8.73 million	1.84 million	Not Optionable
RXST RxSight	220	40.92 million	37.00 million	Optionable
SNWV Sanuwave Health	40	8.57 million	7.29 million	N/A

BLUA, BFLY, SNWV, and RXST Headlines

Recent News About These Companies

Sanuwave Health (NASDAQ:SNWV) Releases Earnings Results, Beats Estimates By $0.10 EPS

August 10, 2025 | marketbeat.com

Sanuwave Health (NASDAQ:SNWV) Rating Increased to Buy at Wall Street Zen

August 10, 2025 | marketbeat.com

SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

Sanuwave (SNWV) Q2 Revenue Jumps 42%

August 8, 2025 | fool.com

Sanuwave Announces Q2 FY2025 Financial Results

August 8, 2025 | globenewswire.com

Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results

August 4, 2025 | globenewswire.com

Brokers Issue Forecasts for Sanuwave Health Q2 Earnings

August 1, 2025 | marketbeat.com

Roth Capital Begins Coverage on Sanuwave Health (NASDAQ:SNWV)

July 30, 2025 | marketbeat.com

Sanuwave Health to Present at Canaccord Genuity Growth Conference

July 22, 2025 | globenewswire.com

Sanuwave: High Growth Wound Care Tech Primed For A Breakout

June 11, 2025 | seekingalpha.com

Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations

June 3, 2025 | globenewswire.com

SANUWAVE Health, Inc. (SNWV): A Bull Case Theory

May 29, 2025 | insidermonkey.com

Sanuwave Health Appoints Greg Bazar to Board of Directors

May 28, 2025 | globenewswire.com

Sanuwave Health Selected for Inclusion in Russell 2000Â® Index

May 28, 2025 | globenewswire.com

Insider Selling: SANUWAVE Health, Inc. (NASDAQ:SNWV) Insider Sells 3,639 Shares of Stock

May 17, 2025 | insidertrades.com

SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript

May 9, 2025 | seekingalpha.com

Sanuwave Announces Q1 FY2025 Financial Results

May 9, 2025 | globenewswire.com

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

May 5, 2025 | globenewswire.com

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

April 8, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLUA, BFLY, SNWV, and RXST Company Descriptions

Butterfly Network NYSE:BFLY

$1.42 +0.04 (+2.54%)

Closing price 03:59 PM Eastern

Extended Trading

$1.41 -0.01 (-0.35%)

As of 04:10 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

BlueRiver Acquisition NYSE:BLUA

BlueRiver Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of technology, media, telecom, and entertainment industries. The company was incorporated in 2020 and is based in San Antonio, Texas.

RxSight NASDAQ:RXST

$8.45 -0.36 (-4.09%)

Closing price 04:00 PM Eastern

Extended Trading

$8.44 0.00 (-0.06%)

As of 04:10 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sanuwave Health NASDAQ:SNWV

$39.45 +2.74 (+7.46%)

As of 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time